nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP2D6—breast cancer	0.181	0.538	CbGaD
Palonosetron—CYP3A4—breast cancer	0.155	0.462	CbGaD
Palonosetron—CYP1A2—Anastrozole—breast cancer	0.0461	0.109	CbGbCtD
Palonosetron—CYP1A2—Toremifene—breast cancer	0.0422	0.0993	CbGbCtD
Palonosetron—CYP3A4—Exemestane—breast cancer	0.0319	0.0751	CbGbCtD
Palonosetron—CYP2D6—Idarubicin—breast cancer	0.0288	0.0678	CbGbCtD
Palonosetron—CYP3A4—Letrozole—breast cancer	0.0271	0.0638	CbGbCtD
Palonosetron—CYP3A4—Anastrozole—breast cancer	0.0242	0.0569	CbGbCtD
Palonosetron—CYP3A4—Toremifene—breast cancer	0.0221	0.052	CbGbCtD
Palonosetron—CYP3A4—Fulvestrant—breast cancer	0.0205	0.0484	CbGbCtD
Palonosetron—CYP3A4—Thiotepa—breast cancer	0.0183	0.0431	CbGbCtD
Palonosetron—CYP3A4—Ixabepilone—breast cancer	0.0167	0.0394	CbGbCtD
Palonosetron—CYP3A4—Lapatinib—breast cancer	0.0161	0.038	CbGbCtD
Palonosetron—CYP1A2—Tamoxifen—breast cancer	0.0154	0.0363	CbGbCtD
Palonosetron—CYP2D6—Vinorelbine—breast cancer	0.0141	0.0331	CbGbCtD
Palonosetron—CYP2D6—Tamoxifen—breast cancer	0.0127	0.0299	CbGbCtD
Palonosetron—CYP3A4—Raloxifene—breast cancer	0.0122	0.0288	CbGbCtD
Palonosetron—CYP1A2—Fluorouracil—breast cancer	0.0114	0.0267	CbGbCtD
Palonosetron—CYP3A4—Vinorelbine—breast cancer	0.00894	0.0211	CbGbCtD
Palonosetron—CYP2D6—Vinblastine—breast cancer	0.00867	0.0204	CbGbCtD
Palonosetron—CYP3A4—Tamoxifen—breast cancer	0.00807	0.019	CbGbCtD
Palonosetron—CYP3A4—Mitoxantrone—breast cancer	0.00787	0.0185	CbGbCtD
Palonosetron—CYP3A4—Paclitaxel—breast cancer	0.00628	0.0148	CbGbCtD
Palonosetron—CYP3A4—Irinotecan—breast cancer	0.0062	0.0146	CbGbCtD
Palonosetron—CYP3A4—Vinblastine—breast cancer	0.00551	0.013	CbGbCtD
Palonosetron—CYP2D6—Doxorubicin—breast cancer	0.00533	0.0125	CbGbCtD
Palonosetron—CYP3A4—Docetaxel—breast cancer	0.00454	0.0107	CbGbCtD
Palonosetron—CYP3A4—Doxorubicin—breast cancer	0.00339	0.00797	CbGbCtD
Palonosetron—Praziquantel—CYP2D6—breast cancer	0.00119	0.538	CrCbGaD
Palonosetron—Praziquantel—CYP3A4—breast cancer	0.00102	0.462	CrCbGaD
Palonosetron—Tachycardia—Capecitabine—breast cancer	5.16e-05	0.00027	CcSEcCtD
Palonosetron—Cardiac disorder—Methotrexate—breast cancer	5.14e-05	0.000269	CcSEcCtD
Palonosetron—Skin disorder—Capecitabine—breast cancer	5.14e-05	0.000269	CcSEcCtD
Palonosetron—Urinary tract disorder—Epirubicin—breast cancer	5.12e-05	0.000268	CcSEcCtD
Palonosetron—Hypotension—Docetaxel—breast cancer	5.1e-05	0.000267	CcSEcCtD
Palonosetron—Connective tissue disorder—Epirubicin—breast cancer	5.1e-05	0.000266	CcSEcCtD
Palonosetron—Abdominal pain—Paclitaxel—breast cancer	5.09e-05	0.000266	CcSEcCtD
Palonosetron—Body temperature increased—Paclitaxel—breast cancer	5.09e-05	0.000266	CcSEcCtD
Palonosetron—Urethral disorder—Epirubicin—breast cancer	5.08e-05	0.000266	CcSEcCtD
Palonosetron—Hepatobiliary disease—Doxorubicin—breast cancer	5.06e-05	0.000264	CcSEcCtD
Palonosetron—Epistaxis—Doxorubicin—breast cancer	5.04e-05	0.000264	CcSEcCtD
Palonosetron—Anorexia—Capecitabine—breast cancer	5.04e-05	0.000264	CcSEcCtD
Palonosetron—Angiopathy—Methotrexate—breast cancer	5.03e-05	0.000263	CcSEcCtD
Palonosetron—Vomiting—Irinotecan—breast cancer	5.02e-05	0.000263	CcSEcCtD
Palonosetron—Vomiting—Mitoxantrone—breast cancer	5.02e-05	0.000263	CcSEcCtD
Palonosetron—Sinusitis—Doxorubicin—breast cancer	5.01e-05	0.000262	CcSEcCtD
Palonosetron—Immune system disorder—Methotrexate—breast cancer	5.01e-05	0.000262	CcSEcCtD
Palonosetron—Dizziness—Fluorouracil—breast cancer	5e-05	0.000262	CcSEcCtD
Palonosetron—Mediastinal disorder—Methotrexate—breast cancer	4.99e-05	0.000261	CcSEcCtD
Palonosetron—Rash—Mitoxantrone—breast cancer	4.98e-05	0.00026	CcSEcCtD
Palonosetron—Rash—Irinotecan—breast cancer	4.98e-05	0.00026	CcSEcCtD
Palonosetron—Dermatitis—Mitoxantrone—breast cancer	4.98e-05	0.00026	CcSEcCtD
Palonosetron—Dermatitis—Irinotecan—breast cancer	4.98e-05	0.00026	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Docetaxel—breast cancer	4.98e-05	0.00026	CcSEcCtD
Palonosetron—Chills—Methotrexate—breast cancer	4.97e-05	0.00026	CcSEcCtD
Palonosetron—Headache—Mitoxantrone—breast cancer	4.95e-05	0.000259	CcSEcCtD
Palonosetron—Headache—Irinotecan—breast cancer	4.95e-05	0.000259	CcSEcCtD
Palonosetron—Hypotension—Capecitabine—breast cancer	4.94e-05	0.000258	CcSEcCtD
Palonosetron—Insomnia—Docetaxel—breast cancer	4.94e-05	0.000258	CcSEcCtD
Palonosetron—Paraesthesia—Docetaxel—breast cancer	4.91e-05	0.000256	CcSEcCtD
Palonosetron—Alopecia—Methotrexate—breast cancer	4.9e-05	0.000256	CcSEcCtD
Palonosetron—Vomiting—Gemcitabine—breast cancer	4.89e-05	0.000256	CcSEcCtD
Palonosetron—Bradycardia—Doxorubicin—breast cancer	4.89e-05	0.000255	CcSEcCtD
Palonosetron—Dyspnoea—Docetaxel—breast cancer	4.87e-05	0.000255	CcSEcCtD
Palonosetron—Somnolence—Docetaxel—breast cancer	4.86e-05	0.000254	CcSEcCtD
Palonosetron—Mental disorder—Methotrexate—breast cancer	4.86e-05	0.000254	CcSEcCtD
Palonosetron—Rash—Gemcitabine—breast cancer	4.85e-05	0.000254	CcSEcCtD
Palonosetron—Dermatitis—Gemcitabine—breast cancer	4.85e-05	0.000253	CcSEcCtD
Palonosetron—Eye disorder—Epirubicin—breast cancer	4.85e-05	0.000253	CcSEcCtD
Palonosetron—Tinnitus—Epirubicin—breast cancer	4.84e-05	0.000253	CcSEcCtD
Palonosetron—Malnutrition—Methotrexate—breast cancer	4.82e-05	0.000252	CcSEcCtD
Palonosetron—Erythema—Methotrexate—breast cancer	4.82e-05	0.000252	CcSEcCtD
Palonosetron—Headache—Gemcitabine—breast cancer	4.82e-05	0.000252	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Capecitabine—breast cancer	4.82e-05	0.000252	CcSEcCtD
Palonosetron—Cardiac disorder—Epirubicin—breast cancer	4.81e-05	0.000252	CcSEcCtD
Palonosetron—Vomiting—Fluorouracil—breast cancer	4.81e-05	0.000252	CcSEcCtD
Palonosetron—Dyspepsia—Docetaxel—breast cancer	4.81e-05	0.000251	CcSEcCtD
Palonosetron—Insomnia—Capecitabine—breast cancer	4.78e-05	0.00025	CcSEcCtD
Palonosetron—Rash—Fluorouracil—breast cancer	4.77e-05	0.000249	CcSEcCtD
Palonosetron—Dermatitis—Fluorouracil—breast cancer	4.77e-05	0.000249	CcSEcCtD
Palonosetron—Paraesthesia—Capecitabine—breast cancer	4.75e-05	0.000248	CcSEcCtD
Palonosetron—Decreased appetite—Docetaxel—breast cancer	4.75e-05	0.000248	CcSEcCtD
Palonosetron—Hypersensitivity—Paclitaxel—breast cancer	4.75e-05	0.000248	CcSEcCtD
Palonosetron—Headache—Fluorouracil—breast cancer	4.74e-05	0.000248	CcSEcCtD
Palonosetron—Urinary tract disorder—Doxorubicin—breast cancer	4.74e-05	0.000248	CcSEcCtD
Palonosetron—Dysgeusia—Methotrexate—breast cancer	4.72e-05	0.000247	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Docetaxel—breast cancer	4.72e-05	0.000247	CcSEcCtD
Palonosetron—Connective tissue disorder—Doxorubicin—breast cancer	4.72e-05	0.000246	CcSEcCtD
Palonosetron—Dyspnoea—Capecitabine—breast cancer	4.72e-05	0.000246	CcSEcCtD
Palonosetron—Fatigue—Docetaxel—breast cancer	4.71e-05	0.000246	CcSEcCtD
Palonosetron—Angiopathy—Epirubicin—breast cancer	4.71e-05	0.000246	CcSEcCtD
Palonosetron—Urethral disorder—Doxorubicin—breast cancer	4.7e-05	0.000246	CcSEcCtD
Palonosetron—Nausea—Mitoxantrone—breast cancer	4.69e-05	0.000245	CcSEcCtD
Palonosetron—Nausea—Irinotecan—breast cancer	4.69e-05	0.000245	CcSEcCtD
Palonosetron—Immune system disorder—Epirubicin—breast cancer	4.68e-05	0.000245	CcSEcCtD
Palonosetron—Mediastinal disorder—Epirubicin—breast cancer	4.67e-05	0.000244	CcSEcCtD
Palonosetron—Constipation—Docetaxel—breast cancer	4.67e-05	0.000244	CcSEcCtD
Palonosetron—Pain—Docetaxel—breast cancer	4.67e-05	0.000244	CcSEcCtD
Palonosetron—Dyspepsia—Capecitabine—breast cancer	4.66e-05	0.000243	CcSEcCtD
Palonosetron—Chills—Epirubicin—breast cancer	4.65e-05	0.000243	CcSEcCtD
Palonosetron—Arrhythmia—Epirubicin—breast cancer	4.63e-05	0.000242	CcSEcCtD
Palonosetron—Asthenia—Paclitaxel—breast cancer	4.62e-05	0.000242	CcSEcCtD
Palonosetron—Decreased appetite—Capecitabine—breast cancer	4.6e-05	0.00024	CcSEcCtD
Palonosetron—Alopecia—Epirubicin—breast cancer	4.58e-05	0.00024	CcSEcCtD
Palonosetron—Nausea—Gemcitabine—breast cancer	4.57e-05	0.000239	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Capecitabine—breast cancer	4.57e-05	0.000239	CcSEcCtD
Palonosetron—Fatigue—Capecitabine—breast cancer	4.56e-05	0.000238	CcSEcCtD
Palonosetron—Pruritus—Paclitaxel—breast cancer	4.56e-05	0.000238	CcSEcCtD
Palonosetron—Mental disorder—Epirubicin—breast cancer	4.54e-05	0.000237	CcSEcCtD
Palonosetron—Constipation—Capecitabine—breast cancer	4.52e-05	0.000236	CcSEcCtD
Palonosetron—Pain—Capecitabine—breast cancer	4.52e-05	0.000236	CcSEcCtD
Palonosetron—Malnutrition—Epirubicin—breast cancer	4.51e-05	0.000236	CcSEcCtD
Palonosetron—Erythema—Epirubicin—breast cancer	4.51e-05	0.000236	CcSEcCtD
Palonosetron—Nausea—Fluorouracil—breast cancer	4.5e-05	0.000235	CcSEcCtD
Palonosetron—Eye disorder—Doxorubicin—breast cancer	4.48e-05	0.000234	CcSEcCtD
Palonosetron—Tinnitus—Doxorubicin—breast cancer	4.47e-05	0.000234	CcSEcCtD
Palonosetron—Gastrointestinal pain—Docetaxel—breast cancer	4.47e-05	0.000233	CcSEcCtD
Palonosetron—Anaemia—Methotrexate—breast cancer	4.46e-05	0.000233	CcSEcCtD
Palonosetron—Cardiac disorder—Doxorubicin—breast cancer	4.45e-05	0.000233	CcSEcCtD
Palonosetron—Flatulence—Epirubicin—breast cancer	4.45e-05	0.000233	CcSEcCtD
Palonosetron—Dysgeusia—Epirubicin—breast cancer	4.42e-05	0.000231	CcSEcCtD
Palonosetron—Diarrhoea—Paclitaxel—breast cancer	4.41e-05	0.00023	CcSEcCtD
Palonosetron—Angiopathy—Doxorubicin—breast cancer	4.35e-05	0.000228	CcSEcCtD
Palonosetron—Immune system disorder—Doxorubicin—breast cancer	4.33e-05	0.000227	CcSEcCtD
Palonosetron—Gastrointestinal pain—Capecitabine—breast cancer	4.32e-05	0.000226	CcSEcCtD
Palonosetron—Mediastinal disorder—Doxorubicin—breast cancer	4.32e-05	0.000226	CcSEcCtD
Palonosetron—Body temperature increased—Docetaxel—breast cancer	4.32e-05	0.000226	CcSEcCtD
Palonosetron—Abdominal pain—Docetaxel—breast cancer	4.32e-05	0.000226	CcSEcCtD
Palonosetron—Chills—Doxorubicin—breast cancer	4.31e-05	0.000225	CcSEcCtD
Palonosetron—Arrhythmia—Doxorubicin—breast cancer	4.29e-05	0.000224	CcSEcCtD
Palonosetron—Dizziness—Paclitaxel—breast cancer	4.26e-05	0.000223	CcSEcCtD
Palonosetron—Alopecia—Doxorubicin—breast cancer	4.24e-05	0.000222	CcSEcCtD
Palonosetron—Mental disorder—Doxorubicin—breast cancer	4.2e-05	0.00022	CcSEcCtD
Palonosetron—Body temperature increased—Capecitabine—breast cancer	4.18e-05	0.000219	CcSEcCtD
Palonosetron—Abdominal pain—Capecitabine—breast cancer	4.18e-05	0.000219	CcSEcCtD
Palonosetron—Convulsion—Methotrexate—breast cancer	4.18e-05	0.000218	CcSEcCtD
Palonosetron—Malnutrition—Doxorubicin—breast cancer	4.18e-05	0.000218	CcSEcCtD
Palonosetron—Erythema—Doxorubicin—breast cancer	4.18e-05	0.000218	CcSEcCtD
Palonosetron—Anaemia—Epirubicin—breast cancer	4.17e-05	0.000218	CcSEcCtD
Palonosetron—Flatulence—Doxorubicin—breast cancer	4.12e-05	0.000215	CcSEcCtD
Palonosetron—Arthralgia—Methotrexate—breast cancer	4.11e-05	0.000215	CcSEcCtD
Palonosetron—Myalgia—Methotrexate—breast cancer	4.11e-05	0.000215	CcSEcCtD
Palonosetron—Vomiting—Paclitaxel—breast cancer	4.1e-05	0.000214	CcSEcCtD
Palonosetron—Dysgeusia—Doxorubicin—breast cancer	4.09e-05	0.000214	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.08e-05	0.000213	CcSEcCtD
Palonosetron—Rash—Paclitaxel—breast cancer	4.06e-05	0.000212	CcSEcCtD
Palonosetron—Dermatitis—Paclitaxel—breast cancer	4.06e-05	0.000212	CcSEcCtD
Palonosetron—Discomfort—Methotrexate—breast cancer	4.06e-05	0.000212	CcSEcCtD
Palonosetron—Headache—Paclitaxel—breast cancer	4.04e-05	0.000211	CcSEcCtD
Palonosetron—Hypersensitivity—Docetaxel—breast cancer	4.02e-05	0.00021	CcSEcCtD
Palonosetron—Anaphylactic shock—Methotrexate—breast cancer	3.94e-05	0.000206	CcSEcCtD
Palonosetron—Asthenia—Docetaxel—breast cancer	3.92e-05	0.000205	CcSEcCtD
Palonosetron—Convulsion—Epirubicin—breast cancer	3.91e-05	0.000204	CcSEcCtD
Palonosetron—Infection—Methotrexate—breast cancer	3.91e-05	0.000204	CcSEcCtD
Palonosetron—Hypertension—Epirubicin—breast cancer	3.9e-05	0.000204	CcSEcCtD
Palonosetron—Hypersensitivity—Capecitabine—breast cancer	3.9e-05	0.000204	CcSEcCtD
Palonosetron—Pruritus—Docetaxel—breast cancer	3.86e-05	0.000202	CcSEcCtD
Palonosetron—Nervous system disorder—Methotrexate—breast cancer	3.86e-05	0.000202	CcSEcCtD
Palonosetron—Anaemia—Doxorubicin—breast cancer	3.86e-05	0.000202	CcSEcCtD
Palonosetron—Arthralgia—Epirubicin—breast cancer	3.84e-05	0.000201	CcSEcCtD
Palonosetron—Myalgia—Epirubicin—breast cancer	3.84e-05	0.000201	CcSEcCtD
Palonosetron—Anxiety—Epirubicin—breast cancer	3.83e-05	0.0002	CcSEcCtD
Palonosetron—Nausea—Paclitaxel—breast cancer	3.83e-05	0.0002	CcSEcCtD
Palonosetron—Skin disorder—Methotrexate—breast cancer	3.82e-05	0.0002	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.82e-05	0.0002	CcSEcCtD
Palonosetron—Discomfort—Epirubicin—breast cancer	3.8e-05	0.000199	CcSEcCtD
Palonosetron—Asthenia—Capecitabine—breast cancer	3.79e-05	0.000198	CcSEcCtD
Palonosetron—Dry mouth—Epirubicin—breast cancer	3.76e-05	0.000196	CcSEcCtD
Palonosetron—Anorexia—Methotrexate—breast cancer	3.75e-05	0.000196	CcSEcCtD
Palonosetron—Pruritus—Capecitabine—breast cancer	3.74e-05	0.000196	CcSEcCtD
Palonosetron—Diarrhoea—Docetaxel—breast cancer	3.74e-05	0.000195	CcSEcCtD
Palonosetron—Anaphylactic shock—Epirubicin—breast cancer	3.68e-05	0.000193	CcSEcCtD
Palonosetron—Hypotension—Methotrexate—breast cancer	3.68e-05	0.000192	CcSEcCtD
Palonosetron—Infection—Epirubicin—breast cancer	3.66e-05	0.000191	CcSEcCtD
Palonosetron—Shock—Epirubicin—breast cancer	3.62e-05	0.000189	CcSEcCtD
Palonosetron—Convulsion—Doxorubicin—breast cancer	3.62e-05	0.000189	CcSEcCtD
Palonosetron—Diarrhoea—Capecitabine—breast cancer	3.62e-05	0.000189	CcSEcCtD
Palonosetron—Nervous system disorder—Epirubicin—breast cancer	3.61e-05	0.000189	CcSEcCtD
Palonosetron—Dizziness—Docetaxel—breast cancer	3.61e-05	0.000189	CcSEcCtD
Palonosetron—Hypertension—Doxorubicin—breast cancer	3.61e-05	0.000189	CcSEcCtD
Palonosetron—Tachycardia—Epirubicin—breast cancer	3.6e-05	0.000188	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Methotrexate—breast cancer	3.59e-05	0.000188	CcSEcCtD
Palonosetron—Skin disorder—Epirubicin—breast cancer	3.58e-05	0.000187	CcSEcCtD
Palonosetron—Insomnia—Methotrexate—breast cancer	3.56e-05	0.000186	CcSEcCtD
Palonosetron—Arthralgia—Doxorubicin—breast cancer	3.56e-05	0.000186	CcSEcCtD
Palonosetron—Myalgia—Doxorubicin—breast cancer	3.56e-05	0.000186	CcSEcCtD
Palonosetron—Anxiety—Doxorubicin—breast cancer	3.54e-05	0.000185	CcSEcCtD
Palonosetron—Paraesthesia—Methotrexate—breast cancer	3.54e-05	0.000185	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.53e-05	0.000185	CcSEcCtD
Palonosetron—Discomfort—Doxorubicin—breast cancer	3.51e-05	0.000184	CcSEcCtD
Palonosetron—Anorexia—Epirubicin—breast cancer	3.51e-05	0.000184	CcSEcCtD
Palonosetron—Dyspnoea—Methotrexate—breast cancer	3.51e-05	0.000183	CcSEcCtD
Palonosetron—Somnolence—Methotrexate—breast cancer	3.5e-05	0.000183	CcSEcCtD
Palonosetron—Dizziness—Capecitabine—breast cancer	3.5e-05	0.000183	CcSEcCtD
Palonosetron—Dry mouth—Doxorubicin—breast cancer	3.48e-05	0.000182	CcSEcCtD
Palonosetron—Vomiting—Docetaxel—breast cancer	3.47e-05	0.000182	CcSEcCtD
Palonosetron—Dyspepsia—Methotrexate—breast cancer	3.47e-05	0.000181	CcSEcCtD
Palonosetron—Rash—Docetaxel—breast cancer	3.44e-05	0.00018	CcSEcCtD
Palonosetron—Hypotension—Epirubicin—breast cancer	3.44e-05	0.00018	CcSEcCtD
Palonosetron—Dermatitis—Docetaxel—breast cancer	3.44e-05	0.00018	CcSEcCtD
Palonosetron—Decreased appetite—Methotrexate—breast cancer	3.42e-05	0.000179	CcSEcCtD
Palonosetron—Headache—Docetaxel—breast cancer	3.42e-05	0.000179	CcSEcCtD
Palonosetron—Anaphylactic shock—Doxorubicin—breast cancer	3.41e-05	0.000178	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Methotrexate—breast cancer	3.4e-05	0.000178	CcSEcCtD
Palonosetron—Fatigue—Methotrexate—breast cancer	3.39e-05	0.000177	CcSEcCtD
Palonosetron—Infection—Doxorubicin—breast cancer	3.39e-05	0.000177	CcSEcCtD
Palonosetron—Pain—Methotrexate—breast cancer	3.37e-05	0.000176	CcSEcCtD
Palonosetron—Vomiting—Capecitabine—breast cancer	3.36e-05	0.000176	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Epirubicin—breast cancer	3.36e-05	0.000175	CcSEcCtD
Palonosetron—Shock—Doxorubicin—breast cancer	3.35e-05	0.000175	CcSEcCtD
Palonosetron—Nervous system disorder—Doxorubicin—breast cancer	3.34e-05	0.000175	CcSEcCtD
Palonosetron—Rash—Capecitabine—breast cancer	3.33e-05	0.000174	CcSEcCtD
Palonosetron—Insomnia—Epirubicin—breast cancer	3.33e-05	0.000174	CcSEcCtD
Palonosetron—Dermatitis—Capecitabine—breast cancer	3.33e-05	0.000174	CcSEcCtD
Palonosetron—Tachycardia—Doxorubicin—breast cancer	3.33e-05	0.000174	CcSEcCtD
Palonosetron—Headache—Capecitabine—breast cancer	3.31e-05	0.000173	CcSEcCtD
Palonosetron—Skin disorder—Doxorubicin—breast cancer	3.31e-05	0.000173	CcSEcCtD
Palonosetron—Paraesthesia—Epirubicin—breast cancer	3.31e-05	0.000173	CcSEcCtD
Palonosetron—Dyspnoea—Epirubicin—breast cancer	3.28e-05	0.000172	CcSEcCtD
Palonosetron—Somnolence—Epirubicin—breast cancer	3.28e-05	0.000171	CcSEcCtD
Palonosetron—Anorexia—Doxorubicin—breast cancer	3.25e-05	0.00017	CcSEcCtD
Palonosetron—Nausea—Docetaxel—breast cancer	3.24e-05	0.00017	CcSEcCtD
Palonosetron—Dyspepsia—Epirubicin—breast cancer	3.24e-05	0.00017	CcSEcCtD
Palonosetron—Gastrointestinal pain—Methotrexate—breast cancer	3.22e-05	0.000168	CcSEcCtD
Palonosetron—Decreased appetite—Epirubicin—breast cancer	3.2e-05	0.000167	CcSEcCtD
Palonosetron—Hypotension—Doxorubicin—breast cancer	3.19e-05	0.000167	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Epirubicin—breast cancer	3.18e-05	0.000166	CcSEcCtD
Palonosetron—Fatigue—Epirubicin—breast cancer	3.18e-05	0.000166	CcSEcCtD
Palonosetron—Pain—Epirubicin—breast cancer	3.15e-05	0.000165	CcSEcCtD
Palonosetron—Constipation—Epirubicin—breast cancer	3.15e-05	0.000165	CcSEcCtD
Palonosetron—Nausea—Capecitabine—breast cancer	3.14e-05	0.000164	CcSEcCtD
Palonosetron—Body temperature increased—Methotrexate—breast cancer	3.11e-05	0.000163	CcSEcCtD
Palonosetron—Abdominal pain—Methotrexate—breast cancer	3.11e-05	0.000163	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.11e-05	0.000162	CcSEcCtD
Palonosetron—Insomnia—Doxorubicin—breast cancer	3.08e-05	0.000161	CcSEcCtD
Palonosetron—Paraesthesia—Doxorubicin—breast cancer	3.06e-05	0.00016	CcSEcCtD
Palonosetron—Dyspnoea—Doxorubicin—breast cancer	3.04e-05	0.000159	CcSEcCtD
Palonosetron—Somnolence—Doxorubicin—breast cancer	3.03e-05	0.000158	CcSEcCtD
Palonosetron—Gastrointestinal pain—Epirubicin—breast cancer	3.01e-05	0.000157	CcSEcCtD
Palonosetron—Dyspepsia—Doxorubicin—breast cancer	3e-05	0.000157	CcSEcCtD
Palonosetron—Decreased appetite—Doxorubicin—breast cancer	2.96e-05	0.000155	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Doxorubicin—breast cancer	2.94e-05	0.000154	CcSEcCtD
Palonosetron—Fatigue—Doxorubicin—breast cancer	2.94e-05	0.000154	CcSEcCtD
Palonosetron—Constipation—Doxorubicin—breast cancer	2.92e-05	0.000152	CcSEcCtD
Palonosetron—Pain—Doxorubicin—breast cancer	2.92e-05	0.000152	CcSEcCtD
Palonosetron—Abdominal pain—Epirubicin—breast cancer	2.91e-05	0.000152	CcSEcCtD
Palonosetron—Body temperature increased—Epirubicin—breast cancer	2.91e-05	0.000152	CcSEcCtD
Palonosetron—Hypersensitivity—Methotrexate—breast cancer	2.9e-05	0.000152	CcSEcCtD
Palonosetron—Asthenia—Methotrexate—breast cancer	2.82e-05	0.000148	CcSEcCtD
Palonosetron—Gastrointestinal pain—Doxorubicin—breast cancer	2.79e-05	0.000146	CcSEcCtD
Palonosetron—Pruritus—Methotrexate—breast cancer	2.79e-05	0.000146	CcSEcCtD
Palonosetron—Hypersensitivity—Epirubicin—breast cancer	2.71e-05	0.000142	CcSEcCtD
Palonosetron—Abdominal pain—Doxorubicin—breast cancer	2.7e-05	0.000141	CcSEcCtD
Palonosetron—Body temperature increased—Doxorubicin—breast cancer	2.7e-05	0.000141	CcSEcCtD
Palonosetron—Diarrhoea—Methotrexate—breast cancer	2.69e-05	0.000141	CcSEcCtD
Palonosetron—Asthenia—Epirubicin—breast cancer	2.64e-05	0.000138	CcSEcCtD
Palonosetron—Pruritus—Epirubicin—breast cancer	2.61e-05	0.000136	CcSEcCtD
Palonosetron—Dizziness—Methotrexate—breast cancer	2.6e-05	0.000136	CcSEcCtD
Palonosetron—Diarrhoea—Epirubicin—breast cancer	2.52e-05	0.000132	CcSEcCtD
Palonosetron—Hypersensitivity—Doxorubicin—breast cancer	2.51e-05	0.000131	CcSEcCtD
Palonosetron—Vomiting—Methotrexate—breast cancer	2.5e-05	0.000131	CcSEcCtD
Palonosetron—Rash—Methotrexate—breast cancer	2.48e-05	0.00013	CcSEcCtD
Palonosetron—Dermatitis—Methotrexate—breast cancer	2.48e-05	0.00013	CcSEcCtD
Palonosetron—Headache—Methotrexate—breast cancer	2.47e-05	0.000129	CcSEcCtD
Palonosetron—Asthenia—Doxorubicin—breast cancer	2.45e-05	0.000128	CcSEcCtD
Palonosetron—Dizziness—Epirubicin—breast cancer	2.44e-05	0.000127	CcSEcCtD
Palonosetron—Pruritus—Doxorubicin—breast cancer	2.41e-05	0.000126	CcSEcCtD
Palonosetron—Vomiting—Epirubicin—breast cancer	2.34e-05	0.000122	CcSEcCtD
Palonosetron—Nausea—Methotrexate—breast cancer	2.34e-05	0.000122	CcSEcCtD
Palonosetron—Diarrhoea—Doxorubicin—breast cancer	2.33e-05	0.000122	CcSEcCtD
Palonosetron—Rash—Epirubicin—breast cancer	2.32e-05	0.000121	CcSEcCtD
Palonosetron—Dermatitis—Epirubicin—breast cancer	2.32e-05	0.000121	CcSEcCtD
Palonosetron—Headache—Epirubicin—breast cancer	2.31e-05	0.000121	CcSEcCtD
Palonosetron—Dizziness—Doxorubicin—breast cancer	2.25e-05	0.000118	CcSEcCtD
Palonosetron—Nausea—Epirubicin—breast cancer	2.19e-05	0.000114	CcSEcCtD
Palonosetron—Vomiting—Doxorubicin—breast cancer	2.17e-05	0.000113	CcSEcCtD
Palonosetron—Rash—Doxorubicin—breast cancer	2.15e-05	0.000112	CcSEcCtD
Palonosetron—Dermatitis—Doxorubicin—breast cancer	2.15e-05	0.000112	CcSEcCtD
Palonosetron—Headache—Doxorubicin—breast cancer	2.14e-05	0.000112	CcSEcCtD
Palonosetron—Nausea—Doxorubicin—breast cancer	2.03e-05	0.000106	CcSEcCtD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—FASN—breast cancer	1.17e-05	0.000258	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—breast cancer	1.16e-05	0.000257	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—UMPS—breast cancer	1.14e-05	0.000253	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ADSL—breast cancer	1.14e-05	0.000253	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PHGDH—breast cancer	1.14e-05	0.000253	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—FHL2—breast cancer	1.14e-05	0.000253	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NME1—breast cancer	1.14e-05	0.000253	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CHST9—breast cancer	1.14e-05	0.000251	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—LDHB—breast cancer	1.12e-05	0.000248	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—BRIP1—breast cancer	1.12e-05	0.000248	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HPSE—breast cancer	1.12e-05	0.000248	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ESRRA—breast cancer	1.12e-05	0.000247	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ANGPTL4—breast cancer	1.12e-05	0.000247	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—COX11—breast cancer	1.08e-05	0.000238	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ABCC1—breast cancer	1.06e-05	0.000235	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTA3—breast cancer	1.06e-05	0.000235	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HMMR—breast cancer	1.06e-05	0.000235	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	1.06e-05	0.000235	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GPI—breast cancer	1.06e-05	0.000234	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HADHB—breast cancer	1.06e-05	0.000234	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PPARGC1B—breast cancer	1.03e-05	0.000227	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.01e-05	0.000224	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ALDH1A1—breast cancer	1.01e-05	0.000223	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ALDH7A1—breast cancer	1.01e-05	0.000223	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	9.98e-06	0.000221	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CDA—breast cancer	9.86e-06	0.000218	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SHMT1—breast cancer	9.86e-06	0.000218	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CA9—breast cancer	9.72e-06	0.000215	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTA4—breast cancer	9.72e-06	0.000215	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—UMPS—breast cancer	9.68e-06	0.000214	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NME1—breast cancer	9.68e-06	0.000214	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—FHL2—breast cancer	9.68e-06	0.000214	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ADSL—breast cancer	9.68e-06	0.000214	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PHGDH—breast cancer	9.68e-06	0.000214	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—BRIP1—breast cancer	9.49e-06	0.00021	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HPSE—breast cancer	9.49e-06	0.00021	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—LDHB—breast cancer	9.49e-06	0.00021	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SLCO1B1—breast cancer	9.49e-06	0.00021	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SLC2A5—breast cancer	9.49e-06	0.00021	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GPX2—breast cancer	9.47e-06	0.000209	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTA2—breast cancer	9.47e-06	0.000209	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GPX4—breast cancer	9.35e-06	0.000207	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SULT1A1—breast cancer	9.35e-06	0.000207	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—APRT—breast cancer	9.17e-06	0.000203	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—IDH1—breast cancer	9.14e-06	0.000202	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTA1—breast cancer	9.14e-06	0.000202	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NAT2—breast cancer	9.03e-06	0.0002	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTA3—breast cancer	9e-06	0.000199	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HMMR—breast cancer	9e-06	0.000199	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ABCC1—breast cancer	9e-06	0.000199	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PPARGC1B—breast cancer	8.72e-06	0.000193	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ESRRA—breast cancer	8.62e-06	0.00019	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ANGPTL4—breast cancer	8.62e-06	0.00019	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	8.49e-06	0.000188	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	8.49e-06	0.000188	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTA4—breast cancer	8.23e-06	0.000182	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CA9—breast cancer	8.23e-06	0.000182	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HADHB—breast cancer	8.17e-06	0.000181	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GPI—breast cancer	8.17e-06	0.000181	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	8.13e-06	0.00018	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	8.05e-06	0.000178	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTA2—breast cancer	8.02e-06	0.000177	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GPX2—breast cancer	8.02e-06	0.000177	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GPX4—breast cancer	7.92e-06	0.000175	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SULT1A1—breast cancer	7.92e-06	0.000175	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—MED12—breast cancer	7.92e-06	0.000175	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—DPYD—breast cancer	7.92e-06	0.000175	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ALDOA—breast cancer	7.8e-06	0.000172	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ALDH7A1—breast cancer	7.79e-06	0.000172	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ALDH1A1—breast cancer	7.79e-06	0.000172	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—IDH1—breast cancer	7.74e-06	0.000171	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTA1—breast cancer	7.74e-06	0.000171	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NAT2—breast cancer	7.65e-06	0.000169	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NCOA3—breast cancer	7.57e-06	0.000167	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SLC2A2—breast cancer	7.52e-06	0.000166	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PHGDH—breast cancer	7.47e-06	0.000165	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ADSL—breast cancer	7.47e-06	0.000165	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—UMPS—breast cancer	7.47e-06	0.000165	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—FHL2—breast cancer	7.47e-06	0.000165	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NME1—breast cancer	7.47e-06	0.000165	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ABCG2—breast cancer	7.36e-06	0.000163	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CPT1A—breast cancer	7.36e-06	0.000163	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—MTR—breast cancer	7.36e-06	0.000163	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HPSE—breast cancer	7.33e-06	0.000162	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—LDHB—breast cancer	7.33e-06	0.000162	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—BRIP1—breast cancer	7.33e-06	0.000162	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HPGDS—breast cancer	7.22e-06	0.00016	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HBA1—breast cancer	7.18e-06	0.000159	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ACHE—breast cancer	7e-06	0.000155	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTT1—breast cancer	7e-06	0.000155	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTA3—breast cancer	6.95e-06	0.000154	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HMMR—breast cancer	6.95e-06	0.000154	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ABCC1—breast cancer	6.95e-06	0.000154	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	6.92e-06	0.000153	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PPARGC1B—breast cancer	6.73e-06	0.000149	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—DPYD—breast cancer	6.71e-06	0.000148	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—MED12—breast cancer	6.71e-06	0.000148	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP17A1—breast cancer	6.63e-06	0.000147	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ALDOA—breast cancer	6.61e-06	0.000146	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ENO1—breast cancer	6.56e-06	0.000145	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PTGS1—breast cancer	6.56e-06	0.000145	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NCOA3—breast cancer	6.41e-06	0.000142	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SLC2A2—breast cancer	6.37e-06	0.000141	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTA4—breast cancer	6.35e-06	0.00014	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CA9—breast cancer	6.35e-06	0.00014	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NCOA2—breast cancer	6.32e-06	0.00014	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	6.3e-06	0.000139	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ABCG2—breast cancer	6.24e-06	0.000138	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CPT1A—breast cancer	6.24e-06	0.000138	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—MTR—breast cancer	6.24e-06	0.000138	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GPX2—breast cancer	6.19e-06	0.000137	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTA2—breast cancer	6.19e-06	0.000137	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—FASN—breast cancer	6.13e-06	0.000135	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HPGDS—breast cancer	6.12e-06	0.000135	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GPX4—breast cancer	6.12e-06	0.000135	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SULT1A1—breast cancer	6.12e-06	0.000135	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—BCHE—breast cancer	6.1e-06	0.000135	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HBA1—breast cancer	6.08e-06	0.000134	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SLC5A5—breast cancer	6.03e-06	0.000133	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTA1—breast cancer	5.97e-06	0.000132	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—IDH1—breast cancer	5.97e-06	0.000132	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTT1—breast cancer	5.93e-06	0.000131	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ACHE—breast cancer	5.93e-06	0.000131	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NAT2—breast cancer	5.91e-06	0.000131	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NQO1—breast cancer	5.82e-06	0.000129	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SLC2A1—breast cancer	5.82e-06	0.000129	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP3A4—breast cancer	5.68e-06	0.000125	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP17A1—breast cancer	5.62e-06	0.000124	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP1B1—breast cancer	5.58e-06	0.000123	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ENO1—breast cancer	5.56e-06	0.000123	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PTGS1—breast cancer	5.56e-06	0.000123	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	5.54e-06	0.000122	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HSP90AA1—breast cancer	5.47e-06	0.000121	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	5.47e-06	0.000121	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP2D6—breast cancer	5.45e-06	0.000121	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NCOA2—breast cancer	5.35e-06	0.000118	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NCOA1—breast cancer	5.32e-06	0.000118	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—STK11—breast cancer	5.25e-06	0.000116	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP19A1—breast cancer	5.25e-06	0.000116	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—FASN—breast cancer	5.19e-06	0.000115	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—MED12—breast cancer	5.18e-06	0.000114	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—DPYD—breast cancer	5.18e-06	0.000114	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—BCHE—breast cancer	5.17e-06	0.000114	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SLC5A5—breast cancer	5.11e-06	0.000113	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ALDOA—breast cancer	5.1e-06	0.000113	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NCOA3—breast cancer	4.95e-06	0.000109	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NQO1—breast cancer	4.93e-06	0.000109	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SLC2A1—breast cancer	4.93e-06	0.000109	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SLC2A2—breast cancer	4.91e-06	0.000109	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—COMT—breast cancer	4.88e-06	0.000108	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTP1—breast cancer	4.86e-06	0.000107	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.83e-06	0.000107	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—MTR—breast cancer	4.81e-06	0.000106	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ABCG2—breast cancer	4.81e-06	0.000106	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CPT1A—breast cancer	4.81e-06	0.000106	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP3A4—breast cancer	4.81e-06	0.000106	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HMOX1—breast cancer	4.79e-06	0.000106	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.78e-06	0.000106	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ITPR1—breast cancer	4.78e-06	0.000106	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP1B1—breast cancer	4.73e-06	0.000105	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HPGDS—breast cancer	4.72e-06	0.000104	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HBA1—breast cancer	4.69e-06	0.000104	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HSP90AA1—breast cancer	4.64e-06	0.000102	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ABCB1—breast cancer	4.6e-06	0.000102	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ACHE—breast cancer	4.58e-06	0.000101	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTT1—breast cancer	4.58e-06	0.000101	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—TYMS—breast cancer	4.51e-06	9.98e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NCOA1—breast cancer	4.51e-06	9.97e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PLA2G4A—breast cancer	4.46e-06	9.86e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NCOR1—breast cancer	4.46e-06	9.86e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTM1—breast cancer	4.46e-06	9.86e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—STK11—breast cancer	4.45e-06	9.83e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP19A1—breast cancer	4.45e-06	9.83e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP17A1—breast cancer	4.34e-06	9.58e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PTGS1—breast cancer	4.29e-06	9.49e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ENO1—breast cancer	4.29e-06	9.49e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GPX1—breast cancer	4.27e-06	9.44e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP1A1—breast cancer	4.23e-06	9.35e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP2D6—breast cancer	4.21e-06	9.3e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ERCC2—breast cancer	4.19e-06	9.27e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.17e-06	9.22e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—COMT—breast cancer	4.13e-06	9.13e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NCOA2—breast cancer	4.13e-06	9.13e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTP1—breast cancer	4.11e-06	9.09e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HMOX1—breast cancer	4.06e-06	8.97e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ITPR1—breast cancer	4.05e-06	8.95e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—FASN—breast cancer	4.01e-06	8.85e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—BCHE—breast cancer	3.99e-06	8.82e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—MTHFR—breast cancer	3.94e-06	8.72e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SLC5A5—breast cancer	3.94e-06	8.71e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ABCB1—breast cancer	3.89e-06	8.61e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—TYMS—breast cancer	3.82e-06	8.45e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SLC2A1—breast cancer	3.81e-06	8.41e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NQO1—breast cancer	3.81e-06	8.41e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTM1—breast cancer	3.78e-06	8.35e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NCOR1—breast cancer	3.78e-06	8.35e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PLA2G4A—breast cancer	3.78e-06	8.35e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP1B1—breast cancer	3.65e-06	8.06e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CAV1—breast cancer	3.64e-06	8.04e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GPX1—breast cancer	3.62e-06	8e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP1A1—breast cancer	3.58e-06	7.92e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.58e-06	7.91e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ERCC2—breast cancer	3.55e-06	7.85e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NCOA1—breast cancer	3.48e-06	7.69e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—STK11—breast cancer	3.43e-06	7.58e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP19A1—breast cancer	3.43e-06	7.58e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—MTHFR—breast cancer	3.34e-06	7.38e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PIK3CG—breast cancer	3.31e-06	7.32e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—COMT—breast cancer	3.19e-06	7.05e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTP1—breast cancer	3.17e-06	7.02e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HMOX1—breast cancer	3.13e-06	6.92e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ITPR1—breast cancer	3.12e-06	6.9e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CAV1—breast cancer	3.08e-06	6.81e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ABCB1—breast cancer	3e-06	6.64e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—TYMS—breast cancer	2.95e-06	6.52e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.94e-06	6.51e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NCOR1—breast cancer	2.92e-06	6.45e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.92e-06	6.45e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTM1—breast cancer	2.92e-06	6.45e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PIK3CD—breast cancer	2.91e-06	6.44e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ALB—breast cancer	2.88e-06	6.35e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PIK3CG—breast cancer	2.81e-06	6.2e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GPX1—breast cancer	2.79e-06	6.17e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP1A1—breast cancer	2.77e-06	6.11e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NOS3—breast cancer	2.75e-06	6.08e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ERCC2—breast cancer	2.74e-06	6.06e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—MTHFR—breast cancer	2.58e-06	5.7e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PIK3CB—breast cancer	2.54e-06	5.61e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PTGS2—breast cancer	2.52e-06	5.56e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PIK3CD—breast cancer	2.47e-06	5.45e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ALB—breast cancer	2.44e-06	5.38e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CAV1—breast cancer	2.38e-06	5.26e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NOS3—breast cancer	2.33e-06	5.15e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PTEN—breast cancer	2.19e-06	4.85e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PIK3CG—breast cancer	2.17e-06	4.79e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PIK3CB—breast cancer	2.15e-06	4.75e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PTGS2—breast cancer	2.13e-06	4.71e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PIK3CD—breast cancer	1.9e-06	4.21e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ALB—breast cancer	1.88e-06	4.15e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PTEN—breast cancer	1.86e-06	4.11e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NOS3—breast cancer	1.8e-06	3.97e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PIK3CB—breast cancer	1.66e-06	3.67e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PTGS2—breast cancer	1.64e-06	3.63e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PIK3CA—breast cancer	1.55e-06	3.42e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PTEN—breast cancer	1.43e-06	3.17e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PIK3CA—breast cancer	1.31e-06	2.9e-05	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—AKT1—breast cancer	1.26e-06	2.79e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—AKT1—breast cancer	1.07e-06	2.37e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PIK3CA—breast cancer	1.01e-06	2.24e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—AKT1—breast cancer	8.27e-07	1.83e-05	CbGpPWpGaD
